Compare BMM & NGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | BMM | NGEN |
|---|---|---|
| Founded | 2007 | 2017 |
| Country | Canada | Canada |
| Employees | 27 | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 316.1M | 317.6M |
| IPO Year | N/A | N/A |
| Metric | BMM | NGEN |
|---|---|---|
| Price | $5.91 | $4.02 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 123.6K | 107.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.47 | $3.73 |
| 52 Week High | $6.56 | $5.93 |
| Indicator | BMM | NGEN |
|---|---|---|
| Relative Strength Index (RSI) | 66.25 | 40.77 |
| Support Level | $3.49 | $3.76 |
| Resistance Level | $6.56 | $4.50 |
| Average True Range (ATR) | 0.49 | 0.27 |
| MACD | 0.22 | 0.03 |
| Stochastic Oscillator | 77.99 | 33.57 |
Blue Moon Metals Inc is a Canadian exploration stage company which is focused on the exploration and development of mineral resource properties. The company is advancing its Blue Moon polymetallic deposit which contains zinc, gold, silver, and copper. The company also holds the Yava polymetallic project in Nunavut that is in the same volcanic lithologies and south of Glencore's Hackett River deposit. The company is focusing on advancing the Blue Moon and Yava properties.
NervGen Pharma Corp is a clinical-stage biotech company. The company's principal business activity is the discovery, development, and commercialization of pharmaceutical treatments that enable the nervous system to repair itself following damage, whether due to injury or disease. The company's initial target indication is spinal cord injury. The company's pipeline products include NVG-291 and NVG-300.